CorVent Medical
CorVent Medical is a privately held U.S. medical device company that designs and manufactures ICU-standard ventilators and AI-driven remote patient monitoring software for hospitals, post-acute care facilities, government stockpiles, the military, and rural health systems.
- Company typePrivate
- Founded2020
- HeadquartersFargo, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What CorVent Medical does
CorVent Medical is a Fargo, North Dakota-based privately held medical device company that designs and manufactures critical care respiratory ventilation hardware and software for hospitals, post-acute care facilities, government stockpiles, the military, and rural health systems. Founded in 2020 during the COVID-19 pandemic, the company secured FDA Emergency Use Authorization for its RESPOND-19 ventilator in 2020 and received full FDA 510(k) clearance for the commercially branded RESPOND ventilator in November 2024 — the first U.S.-manufactured ventilator to clear the FDA in over 20 years. The RESPOND ventilator is an ICU-standard, lightweight (under 20 lbs) critical care device supporting invasive and non-invasive ventilation for pediatric (≥38 kg) and adult patients, featuring a 3-hour hot-swappable battery, 99.99% antiviral filtration, EMR and nurse call connectivity, and a 5-year warranty with no service contract requirement.
The company's second product, CorVision, is an AI/ML-driven remote patient monitoring SaaS platform that pairs with RESPOND via Bluetooth to provide real-time waveform visualization, pressure-volume loops, and predictive analytics, with planned FDA 510(k) submission in Q4 2025. CorVent monetizes through capital equipment sales (RESPOND) with planned recurring SaaS revenue (CorVision), targeting hospitals, long-term acute care hospitals (LTCHs), skilled nursing facilities (SNFs), Critical Access Hospitals, the Strategic National Stockpile, state and federal emergency reserves, and the U.S. military. Go-to-market is direct field sales with nationwide demos and product evaluations. The company has raised approximately $53.2M in equity capital plus $6.8M in non-dilutive government funding through early 2026, with the latest capital intended to fund commercialization of CorVision and drive the company to profitability.
CorVent Medical firmographics
Firmographics- Name
- CorVent Medical
- Legal name
- CorVent Medical, Inc.
- Website
- https://corventmedical.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- CorVent Medical is a privately held U.S. medical device company that designs and manufactures ICU-standard ventilators and AI-driven remote patient monitoring software for hospitals, post-acute care facilities, government stockpiles, the military, and rural health systems.
- Ownership category
- akta.pro rank
CorVent Medical industry classification
Industry- Product category
- Critical Care Ventilators and Respiratory Care Devices
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home) (HLAHAGAC)
- akta.pro secondary industries
- Post-Acute & Hospital-at-Home Remote Care Platforms (HLACAFAB), Virtual Specialty Care Platforms (tele-stroke, tele-ICU, tele-derm, tele-cardiology) (HLALABAD), Ventilator & Respiratory Care SNFs (HLADADAD)
Keywords
Where CorVent Medical is headquartered
LocationHeadquarters
- HQ city
- Fargo
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
CorVent Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- RESPOND Ventilator Sales: Sale of FDA 510(k)-cleared mechanical ventilators to hospitals, LTCHs, SNFs, Critical Access Hospitals, government stockpiles (Strategic National Stockpile), and military applications. One-time capital equipment purchase with 5-year warranty included.
- CorVision RPM SaaS Platform: Remote patient monitoring software as a service platform integrated with RESPOND ventilators. Subscription-based model expected to fund company to profitability. Planned Q4 2025 510(k) submission for the platform.
- Series B Financing Round: Company opened Series B financing round in October 2025 to support CorVision commercialization and continued growth.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | RESPOND Ventilator - Enterprise |
| Subscription | Annual | CorVision RPM SaaS Platform |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels8 records
CorVent Medical product offering
Product offeringCore offering
CorVent Medical designs, manufactures, and sells the FDA 510(k)-cleared RESPOND critical care ventilator and the CorVision AI/ML-driven remote patient monitoring SaaS platform. The RESPOND ventilator delivers ICU-standard invasive and non-invasive ventilation with a 5-year warranty and no service contracts, while CorVision wirelessly connects via Bluetooth to provide real-time waveform monitoring and predictive analytics. The combined hardware-software ecosystem is sold to acute care hospitals, post-acute care facilities, government stockpiles, military medical operations, and rural health systems.
Product overview
CorVent Medical offers a two-product portfolio centered on respiratory ventilation solutions: the RESPOND® Ventilator (FDA 510(k)-cleared critical care ventilator) as the core hardware product, paired with CorVision™ (AI/ML-driven RPM SaaS platform) as the intelligent software add-on. The products work together via Bluetooth connectivity, enabling remote patient monitoring and predictive analytics for ventilated patients in acute care, post-acute care, and emergency preparedness settings.
Differentiator
Problem solved
Functional benefit
Brands
- RESPOND: RESPOND is a full-featured ICU-standard ventilator designed for simple, safe, and smart respiratory care in acute, post-acute, and stockpile settings.
- CorVision
- RESPOND-19
Products and services
- RESPOND® Ventilator ICU-standard critical care ventilator providing invasive and non-invasive ventilation in pressure and volume modes for pediatric (≥38kg) to adult patients. Features include a 5-year standard warranty with no service or maintenance contracts, hot-swappable battery up to 3 hours, EMR and nurse call connectivity, priority-based alarm system, multi-stage antiviral filtration providing 99.99% protection, and a streamlined lightweight design under 20 lbs. Sold to hospitals, LTCHs, SNFs, Critical Access Hospitals, government stockpiles, and military customers.
- CorVision™ RPM SaaS Platform AI/ML-driven remote patient monitoring SaaS platform that connects wirelessly via Bluetooth to the RESPOND ventilator. Enables real-time monitoring of waveforms, pressure-volume (PV) and pressure-control (PC) loops, displaying PEEP, tidal volume, and respiratory rate. Stores over 4,000 event logs and integrates with hospital EMR systems, telemedicine networks, and rural health infrastructures. Includes predictive intelligence features for ventilation management.
Quantifiable outcome
- Reduce ICU transfers by 50%
- +5 more outcomes
Companies that use CorVent Medical
Customer profileNamed customers2 records
Segments5 records
Ideal customer profiles5 records
CorVent Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability2 records
Feature4 records
CorVent Medical partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered strategic and minor.
- G4 AlliancestrategicStrategic membership in global alliance dedicated to safe surgical, obstetric, trauma, and anesthesia (SOTA) care. Partnership focuses on enhanced access to critical care, capacity building and training, research and development collaboration, and advocacy and policy influence.
- North Dakota State University (NDSU)minorDonated RESPOND ventilator to NDSU health professions programs for training nursing and respiratory care students. Located in NDSU Research and Technology Park area.
Scale indicators8 records
Recent moves7 records
Expansion highlights6 records
CorVent Medical competitors and assessment
Company assessmentBroad incumbents
- Medtronic: Global medical device incumbent whose Puritan Bennett line dominates ICU mechanical ventilation. Directly comparable in ventilator category with vastly larger installed base, GPO contracts, and capital scale.
- Dräger: German medical/safety technology incumbent offering Evita and Savina ICU ventilator families alongside broader hospital equipment portfolio. Comparable on ventilator functionality and acute-care customer overlap.
- GE HealthCare: Large medical equipment OEM offering Carescape R860 ventilator among broader patient monitoring and hospital solutions portfolio. Comparable in serving acute care hospitals with critical care ventilation.
- Getinge: Swedish medtech offering Servo-u and Servo-i ventilator lines alongside surgical and ICU solutions. Comparable in ICU ventilator technology with established hospital relationships.
- Philips Respironics: Philips' hospital ventilation and respiratory care division, including Trilogy and other ventilation platforms. Comparable on respiratory equipment breadth though more diversified across sleep, hospital, and home ventilation.
Direct peers
- Hamilton Medical: Swiss specialist in ICU ventilators (Hamilton-G5, C1, C3, C6) competing head-to-head with RESPOND in the critical care ventilator market. Closest direct peer in product category and target customer.
- Vyaire Medical: Pure-play respiratory care company with Bellavista and other ventilator platforms. Closely comparable as a focused respiratory vendor targeting ICU and post-acute ventilation.
Emerging players
- Mindray: Chinese medical device manufacturer with SV300/SV600 ventilator lines growing presence in U.S. and global markets. Comparable in targeting cost-conscious hospitals with modern ICU ventilator designs.
- BMC Medical: Chinese respiratory device manufacturer offering ventilators and CPAP/BiPAP platforms. Comparable as a cost-disruptive ventilator competitor targeting emerging markets and budget-sensitive providers.
Others
- Masimo: Patient monitoring and connected care company with hospital RPM and predictive analytics platforms. Comparable as an adjacent digital health/RPM ecosystem player whose monitoring capabilities could compete with CorVision.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
CorVent Medical social profiles
Digital presenceCorVent Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
CorVent Medical leadership team
Management profileNumber of profiles
Profiles10 records
CorVent Medical funding detail
Funding detailFunding overview
Funding rounds3 records
Investors7 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CorVent Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CorVent Medical
What does CorVent Medical do?
CorVent Medical designs, manufactures, and sells the FDA 510(k)-cleared RESPOND critical care ventilator and the CorVision AI/ML-driven remote patient monitoring SaaS platform. The RESPOND ventilator delivers ICU-standard invasive and non-invasive ventilation with a 5-year warranty and no service contracts, while CorVision wirelessly connects via Bluetooth to provide real-time waveform monitoring and predictive analytics. The combined hardware-software ecosystem is sold to acute care hospitals, post-acute care facilities, government stockpiles, military medical operations, and rural health systems.
Is CorVent Medical a public or private company?
CorVent Medical is a private company. It is classified as venture growth investor backed and is currently operating.
When was CorVent Medical founded?
CorVent Medical was founded in 2020. It employs 11 to 50 people.
Where is CorVent Medical based?
CorVent Medical is headquartered in Fargo, United States, in the North America region.
How does CorVent Medical make money?
Three revenue lines are on record. RESPOND Ventilator Sales are the primary driver. The others are corVision RPM SaaS Platform and series B Financing Round.
Who are CorVent Medical's main competitors?
Broad incumbents on record are Medtronic, Dräger, GE HealthCare, Getinge and Philips Respironics. Direct peers are Hamilton Medical and Vyaire Medical. Emerging players are Mindray and BMC Medical. Masimo is listed as an others.
Does CorVent Medical have an API?
No public API is recorded for CorVent Medical.
What industry is CorVent Medical in?
CorVent Medical's product category is Critical Care Ventilators and Respiratory Care Devices. Its primary akta.pro industry code is HLAHAGAC, Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home), with a secondary code of HLACAFAB, Post-Acute & Hospital-at-Home Remote Care Platforms. Its SIC code is 3841.